Cart
sales@molnova.com
Nefopam hydrochloride
CAS No. 23327-57-3
Nefopam hydrochloride( —— )
Catalog No. M13669 CAS No. 23327-57-3
Nefopam hydrochloride is a centrally-acting but non-opioid analgesic drug by blocking voltage-gated sodium channel and inhibition of serotonin, dopamine and noradrenaline reuptake.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 10MG | 32 | In Stock |
|
| 25MG | 41 | In Stock |
|
| 50MG | 59 | In Stock |
|
| 100MG | 106 | In Stock |
|
| 200MG | 178 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameNefopam hydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionNefopam hydrochloride is a centrally-acting but non-opioid analgesic drug by blocking voltage-gated sodium channel and inhibition of serotonin, dopamine and noradrenaline reuptake.
-
DescriptionNefopam hydrochloride is a centrally-acting but non-opioid analgesic drug by blocking voltage-gated sodium channel and inhibition of serotonin, dopamine and noradrenaline reuptake.(In Vitro):Nefopam hydrochloride (Fenazoxine hydrochloride) is a non-opioid, non-steroidal, centrally acting analgesic drug that is derivative of the non-sedative benzoxazocine. Constitutively elevated β-catenin leads to a delayed and fibrous fracture repair process, and Nefopam inhibits β-catenin mediated signaling during skin wound repair.
-
In VitroNefopam hydrochloride (Fenazoxine hydrochloride) is a non-opioid, non-steroidal, centrally acting analgesic drug that is derivative of the non-sedative benzoxazocine.Constitutively elevated β-catenin leads to a delayed and fibrous fracture repair process, and Nefopam inhibits β-catenin mediated signaling during skin wound repair.
-
In Vivo——
-
Synonyms——
-
PathwayMembrane Transporter/Ion Channel
-
TargetSodium Channel
-
RecptorSodium Channel
-
Research AreaNeurological Disease
-
Indication——
Chemical Information
-
CAS Number23327-57-3
-
Formula Weight289.8
-
Molecular FormulaC17H20ClNO
-
Purity>98% (HPLC)
-
SolubilityWater: 21 mg/mL (72.46 mM); DMSO: 1 mg/mL (3.45 mM)
-
SMILESCl.CN1CCOC(C2=CC=CC=C2)C2=CC=CC=C2C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. M. S. Evans1, et al, lBr J Anaesth, 2008, 101(5), 610-617.
molnova catalog
related products
-
Ranolazine dihydroch...
An anti-ischemic agent that has been shown to inhibit late I(Na) and I(Kr) and to have antiarrhythmic effects in various preclinical in vitro models.
-
Ethacizine hydrochlo...
Ethacizine hydrochloride (NIK-244) has antiarrhythmic activity, and its effects are related to cardiac activity and can be used to study arrhythmias and myocardial infarction.
-
Flecainide
A class Ic antiarrhythmic agent used to prevent and treat tachyarrhythmias, works by blocking the Nav1.5 sodium channel in the heart.
